Assess the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy using the HCM Risk Calculator from the AHA. Try it our for free now.

2024年5月8日 · Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the …

2020年11月20日 · The proposed approach recognizes that spectrum and is inclusive of roles for cardiologists working outside of HCM centers, those working in primary HCM centers that offer …

2025年2月27日 · High-intensity statin therapy is recommended for all patients with ACS, and with the option to initiate concurrent ezetimibe. A nonstatin lipid-lowering agent (eg, ezetimibe, …

The 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy (AHA/ACC/Multisociety HCM Guideline) provides guidance for clinicians on …

2024年5月29日 · The American Heart Association explains hypertrophic cardiomyopathy (HCM) including obstructive and nonobstructive HCM. Also learn symptoms, diagnosis and treatment …

2024年5月8日 · The following are key points to remember from the 2024 AHA/ACC/multisociety guideline for the management of hypertrophic cardiomyopathy (HCM): Patients with HCM …

hypertrophic cardiomyopathy (HCM) centers with appropriate expertise can be important to optimizing care for patients with HCM. Challenging treatment decisions—where reasonable …

The 2024 AHA/ACC/Multisociety Hypertrophic Cardiomyopathy Guideline provides guidance for clinicians on the management of patients with HCM. The guideline contains updated, evidence …

2020年11月20日 · The following are key perspectives from the 2020 American Heart Association/American College of Cardiology (AHA/ACC) guideline for the management of …